InSilico, Lilly ink AI drug discovery deal worth up to $2.75 billion
Business

InSilico, Lilly ink AI drug discovery deal worth up to $2.75 billion

March 29, 2026
Investing.com
Scroll
InSilico, Lilly ink AI drug discovery deal worth up to $2.75 billion
Read Full Article
Investing.com
Investing.com

Coverage and analysis from Israel. All insights are generated by our AI narrative analysis engine.

Israel
Bias: center
You might also like

Explore More